Maxwell joined InterWest’s life sciences team in 2013 as an Analyst, and was promoted to an Associate in 2014. He has supported investments in multiple sectors of healthcare, including biopharmaceuticals, devices, and digital health. Prior to joining InterWest, he conducted research for the Stanford School of Medicine, producing several publications with the plastic and reconstructive surgery department. Maxwell earned his B.S. in materials science and engineering from Stanford, focusing on biomaterials and their healthcare applications.